Novonesis A S ADR (NVZMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 06-2024 | 12-2023 | |
| Sales | 1,244,762 | 1,156,201 | 1,135,252 | 0 | 666,081 |
| Cost of Goods | 608,997 | 538,085 | 509,157 | N/A | 306,526 |
| Gross Profit | 635,765 | 618,116 | 626,095 | N/A | 359,554 |
| Operating Expenses | 419,229 | 399,675 | 346,547 | 0 | 221,764 |
| Operating Income | 217,532 | 218,526 | 279,704 | N/A | 138,317 |
| Interest Expense | 17,534 | 17,823 | 20,333 | 0 | 25,302 |
| Other Income | 468 | -2,611 | -1,580 | 0 | 20,511 |
| Pre-tax Income | 200,466 | 198,092 | 257,791 | 0 | 133,527 |
| Income Tax | 39,158 | 42,797 | 61,841 | N/A | 33,028 |
| Net Income Continuous | 161,308 | 155,295 | 195,951 | N/A | 100,499 |
| Minority Interests | N/A | N/A | N/A | N/A | -419 |
| Net Income | $161,308 | $155,295 | $195,951 | $N/A | $100,918 |
| EPS Basic Total Ops | 0.35 | 0.33 | 0.42 | N/A | 0.36 |
| EPS Basic Continuous Ops | 0.35 | 0.33 | 0.42 | N/A | 0.36 |
| EPS Diluted Total Ops | 0.35 | 0.33 | 0.42 | N/A | 0.36 |
| EPS Diluted Continuous Ops | 0.35 | 0.33 | 0.42 | N/A | 0.36 |
| EPS Diluted Before Non-Recurring Items | 0.48 | 0.41 | 0.44 | N/A | 0.36 |
| EBITDA(a) | $217,532 | $218,526 | $279,704 | $N/A | $138,317 |